慢性静脉疾病累及深静脉临床研究的核心结局集
本研究采用COMET方法制定慢性静脉疾病累及深静脉干预研究的核心结局集。系统综述与19例患者访谈生成80个结局,经两轮Delphi调查(第一轮233名、第二轮143名利益相关者)就29个结局达成共识,最终确定7个通用结局和6个操作特异性结局。报告这些结局将促进深静脉受累慢性静脉疾病干预措施的比较。
要点
- 核心结局集含7个通用结局:死亡、下肢溃疡、静脉血栓栓塞、出血、生活质量、肢体疼痛、水肿或肢体肿胀。
- 操作特异性结局含6项:装置移位、装置机械故障、通畅性、技术和/或操作成功、再干预、血管并发症。
- 系统综述与19例患者访谈生成80个结局,经两轮Delphi调查后29个结局达成共识。
核心结论
- 制定了针对慢性静脉疾病累及深静脉干预研究的核心结局集,包含7个通用结局和6个操作特异性结局,报告这些结局将促进干预措施的比较。
研究设计与样本
- 采用COMET方法制定核心结局集,通过系统综述和19例深静脉血栓后血栓形成综合征患者的访谈生成结局长列表,经指导组提炼后用于Delphi调查。
- 患者和医疗从业者在Delphi调查中使用9点Likert量表对每个结局的重要性进行评分,第一轮未达共识标准的结局在第二轮重新排序。
- 达到关键重要标准的结局在患者与国际专家的最终会议上讨论以形成核心结局集。
主要发现
- 系统综述与访谈生成80个结局进入Delphi流程,第一轮233名利益相关者应答,第二轮143名应答。
- 29个结局达成共识被认定为关键重要,最终会议讨论后产生7个通用结局和6个操作特异性结局,因部分结局并非适用于所有慢性静脉疾病患者。
- 通用结局为死亡、下肢溃疡、静脉血栓栓塞、出血、生活质量、肢体疼痛、水肿或肢体肿胀。
- 操作特异性结局为装置移位、装置机械故障、通畅性、技术和/或操作成功、再干预、血管并发症。
关键数值与推荐
- Delphi调查采用9点Likert量表评分重要性,第一轮未达共识标准的结局在第二轮重新排序。
- 29个结局达成共识被认定为关键重要,最终形成7个通用结局和6个操作特异性结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic venous disease (CVD) is a debilitating disease that results in significant morbidity and costs. A lack of standardised outcome reporting has made it difficult to evaluate the impact of interventions for CVD involving the deep veins. This study aimed to develop a core outcome set (COS) for studies evaluating interventions for this subset of CVD. METHODS: The COS was developed using the Core Outcome Measures in Effectiveness Trials (COMET) methodology. A systematic review and interviews with 19 patients experiencing post-thrombotic syndrome after deep vein thrombosis generated a longlist of outcomes, which was then refined by a steering group. Each outcome was rated on importance by patients and healthcare practitioners using a 9 point Likert scale within a Delphi survey. Outcomes not meeting consensus criteria in the first round were re-prioritised in a second round. Outcomes meeting the criteria for being critically important were discussed in a final meeting between patients and international experts to develop the COS. RESULTS: The review and interviews generated 80 outcomes, which entered the Delphi process. In total, 233 stakeholders responded in the first round and 143 in the second round. Consensus was reached on 29 outcomes deemed critically important. These outcomes were discussed in the final meeting to yield seven general outcomes and six procedure specific outcomes, since some outcomes were not relevant to all patients with CVD. The general outcomes were death, lower limb ulceration, venous thromboembolism, bleeding, quality of life, limb pain, and oedema or limb swelling. The procedure specific outcomes were device migration, device mechanical failure, patency, technical and/or procedural success, re-intervention, and vascular complications. CONCLUSION: A COS was developed for studies evaluating interventions for CVD involving the deep veins, comprising seven general outcomes and six procedure specific outcomes. Reporting these outcomes will promote comparison of interventions for CVD involving the deep veins.
引用
- Hudson G, Osborne-Grinter M, Staniszewska A, et al. Editor's Choice - A Core Outcome Set for Clinical Studies on Chronic Venous Disease Involving the Deep Veins. Eur J Vasc Endovasc Surg. 2025. PMID: 40188862. doi:10.1016/j.ejvs.2025.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。